Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 10.9.2024Takeda Manufacturing Austria AG (TKM-5)97250KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml/20 g (liek.inj.skl.))10.9.2024O
 9.9.2024Bausch Health Ireland Limited (BAU-1)3824EClefirem (tbl flm 28x14 mg (blis.Al/PVC/Al/OPA))10.9.2024U
 9.9.2024Egis Pharmaceuticals PLC (EGI)02429TISERCIN (tbl flm 50x25 mg (liek.skl.hnedá))5.9.2024O
 9.9.2024Egis Pharmaceuticals PLC (EGI)2589EBozilos (tbl flm 28x14 mg (blis.Al/PVC/Al/OPA))9.9.2024U
 8.9.2024Wörwag Pharma GmbH & Co. KG (WGP-1)2059ESitagliptin Wörwag 100 mg (tbl film 98x100 mg (blis.PVC/PVDC/Al))9.9.2024Z
 7.9.2024Novo Nordisk A/S (NOO)8478ANovoEight 1000 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x1000 IU+4 ml solv.+1 adaptér inj.liek. (liek.inj.skl.+striek.inj.napl.skl.))6.9.2024R
 6.9.2024Wörwag Pharma GmbH & Co. KG (WGP-1)2058ESitagliptin Wörwag 100 mg (tbl film 30x100 mg (blis.PVC/PVDC/Al))9.9.2024Z
 6.9.2024ratiopharm GmbH (RAT)65357Penbene (tbl flm 30x1 MU (blis.PVC/PVDC/Al))6.9.2024O
 6.9.2024Mylan Ireland Limited (MNY)8549DAbiraterone Mylan 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.Al/PVC/PE/PVDC))30.11.2024Z
 6.9.2024B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))5.9.2024R
 6.9.2024Boehringer Ingelheim International GmbH (BOE)81590Mirapexin 0,26 mg tablety s predĺženým uvoľňovaním (tbl plg 30(3x10)x0,26 mg)4.9.2024Z
 6.9.2024Eli Lilly Nederland B.V. (LIL-NL-2)6733EMounjaro 2,5 mg/dávka KwikPen injekčný roztok v naplnenom pere (sol inj 1x2,4 ml/10 mg (pero napl. - KwikPen))6.9.2024U
 6.9.2024Eli Lilly Nederland B.V. (LIL-NL-2)6736EMounjaro 5 mg/dávka KwikPen injekčný roztok v naplnenom pere (sol inj 3x2,4 ml/20 mg (pero napl. - KwikPen))6.9.2024U
 5.9.2024Teva B.V. (TEV-NL-4)58792Ecobec 100 µg (aer ora 200x100 µg/1 dávka (obal Al tlak.+aplik.))5.9.2024O
 5.9.2024Teva B.V. (TEV-NL-4)58793Ecobec 250 µg (aer ora 200x250 µg/1 dávka (obal Al tlak.+aplik.))5.9.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)